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Background: Implantation of a single-piece-acrylic intraocular lens (SPA-IOL) in the ciliary sulcus during
phacoemulsification complicated with posterior capsule tear (PCT) may be associated with severe complications.
The purpose of this study was to report the efficacy and safety of sulcus implantation of a SPA-IOL, designed for
both in-the-bag and sulcus positioning.
Methods: A prospective cross-sectional study including 12 patients, who underwent phacoemulsification with PCT
and sulcus implantation of SPA-IOL designed for both in-the-bag and sulcus positioning (Seelens AF, Hanita, Israel)
between January 2009 and March 2012 (follow-up 12–37 months). Preoperatively corrected distance visual acuity
(CDVA), subjective refraction and intraocular pressure (IOP) were recorded. Postoperative evaluation included
anamnesis for IOL edge symptoms and transient visual obscurations (TVO) along with CDVA, subjective refraction
IOP, anterior segment biomicroscopy, gonioscopy, assessment of IOL centration, fundus biomicroscopy and
spectral-domain optical coherence tomography of the macula.
Results: Preoperatively, mean CDVA was 0.84 ± 0.60 LogMAR (Counting Finger-20/33) improving to 0.18 ± 0.13
LogMAR (20/40-20/20) at last examination (p = 0.004), as all the patients gained better CDVA. Mean preoperative
spherical equivalent was −0.2 ± 2.5 Diopter (D) (−4.0D to +5.4D) reaching −1.9 ± 0.9 (−4.0D to −0.6D) at last examination
(p = 0.12). Mean preoperative refractive astigmatism magnitude was 1.0 ± 0.6D (0.3D to 2.3D) changing to 1.1 ± 1.0D
(0.0D to 3.0D) at last examination (p = 0.88). Mean preoperative IOP was 14.7 ± 3.2 mmHg (11–23 mmHg) without
medications reaching 15.9 ± 3.3 mmHg (10–21 mmHg) at last follow up (p = 0.21). Postoperatively one patient required
two medications for IOP control in his study and contralateral eyes. None of the patients had symptoms of IOL edge or
TVO. There were no intraocular hemorrhages, inflammatory reactions, or pigment dispersion and the IOLs were well
centered in all cases. Central foveal thickness was 280 ± 33 μm (193–310 μm).
Conclusions: Appropriately designed SPA-IOL may be implanted in the ciliary sulcus during phacoemulsification with
PCT rather than switching to another backup IOL demanding wound enlargement.
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Figure 1 The single-piece-acrylic intraocular lens used in this
study.
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Posterior capsule tear (PCT) is a common complication
during phacoemulsification with reported incidence ran-
ging from 0.7% to 16%, which may preclude intraocular
lens (IOL) implantation in the capsular bag [1]. Yet, in
some cases IOL may be fixated in the ciliary sulcus if
there is sufficient support of the residual capsule struc-
ture [1].
Single-piece-acrylic (SPA) IOLs have been proved to
be excellent posterior chamber IOLs (PCIOLs) when
placed in the lens capsular bag. However, several studies
have shown that ciliary sulcus implantation of SPA-IOLs
designed solely for capsular bag placement may result in
severe complications [2-8] such as pigment dispersion
syndrome (PDS), secondary intraocular pressure (IOP)
elevation, IOL decentration with edge symptoms, intra-
ocular hemorrhages, recurrent iridocyclitis and cystoid
macular edema.
The purpose of this cross-sectional study was to evalu-
ate the long term follow-up after sulcus fixation of a
SPA-IOL (SeeLens AF, Hanita Lenses, Kibbutz Hanita,
Israel) with appropriate design for implantation in the
capsular bag and the ciliary sulcus.
Methods
We reviewed the medical records of all patients who
underwent phacoemulsification complicated with PCT
between January 1, 2009 and March 31, 2012 in the
Tel Aviv Medical Center, the tertiary Hospital of the
Tel Aviv metropolitan area, affiliated with Tel Aviv
University, Israel.
After approval of this cross-sectional-analysis by the
Investigational Review Board of the Tel Aviv Medical
Center 12 patients, with SPA-IOL implanted in the ci-
liary sulcus, were included in this study. All patients
gave their informed consent before being included in the
study.
The following preoperative data was retrieved from the
patients’ medical records: age, sex, ocular comorbidity,
biometric data, corrected distance visual acuity (CDVA),
subjective refraction and IOP.
Surgery was performed using topical or peribulbar
anesthesia. Two paracentesis ports were opened at the
limbus at the 2 and 10 o’clock positions, and an anterior
chamber maintainer was inserted through another para-
centesis port located inferiorly. Capsulorrhexis was per-
formed using a bent 25-gauge needle or forceps and a
superotemporal, near-limbus, corneal main incision of
2.4 mm was created. Following hydrodissection, phacoe-
mulsification of the nucleus was performed with the Infi-
niti Vision or the Legacy Systems (Alcon Surgical) using
the divide-and-conquer [9] or the stop-and-chop [10]
techniques, and the cortex was removed using an aspirat-
ing cannula. When posterior capsule rupture was noticed,the surgical technique was changed so to avoid or
minimize vitreous loss by maintaining a closed intraocular
system with stable pressure and by injection of ophthalmic
viscosurgical device (OVD) to tamponade the capsule rup-
ture. Nuclear remnants were removed using phacoemulsi-
fication with decreased flow, aspiration and vacuum rate
and cortical remnants were cleaned with an aspirating
cannula. Anterior vitrectomy was performed if vitreous
loss was observed.
Following an evaluation of sufficient capsule support
for IOL fixation in the ciliary sulcus, an OVD was
injected in the anterior chamber and between the anter-
ior capsule and the posterior iris. Then a SPA foldable
PCIOL with 6.0 mm optic, 13.0 mm overall length, 5-
degree posterior angulation, C-loop design and haptic
thickness of 0.31 mm (SeeLens AF, Hanita Lenses,
Kibbutz Hanita, Israel; Figure 1; Additional files 1 and 2)
was implanted through the 2.4 mm incision using an in-
jector. The IOL was first guided and unfolded in the an-
terior chamber. Then using a Sinskey hook the haptics
were placed in the ciliary sulcus and when necessary the
IOL was rotated according to the capsule remnants for
maximal support (Figure 2). At the end of the surgery
miochol was injected to constrict the pupil and assure
that no vitreous was prolapsed to the anterior chamber,
then the OVD was aspirated and the corneal wound was
closed with hydration without suture application.
Postoperative treatment included topical steroids, anti-
biotics and non-steroidal-anti-inflammatory agents ac-
cording to the surgeon’s preference. Usually the patients
were followed at the cataract clinic of our Medical Cen-
ter during the first postoperative month and then sent
for continued care at the community-based-clinics of
their health maintenance organization.
After a postoperative period of at least 1 year the pa-
tients included in this prospective cross-sectional study
were invited for anamnesis evaluating IOL edge symptoms
and transient visual obscurations (TVO) along with the
Figure 2 A slit lamp photograph of a single-piece-acrylic
intraocular lens implanted in the ciliary sulcus. A representative
slit lamp photograph of the right eye 29 months after
phacoemulsification complicated with large posterior capsule tear
and vitreous loss. The eye is quiet; a single-piece-acrylic intraocular
lens is symmetrically centered in the ciliary sulcus with the haptics,
the optic-haptic junctions and the optic edge supported by the
anterior capsule.
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acuity (CDVA), subjective refraction, anterior segment
biomicroscopy, gonioscopy, IOP, assessment of IOL cen-
tration, fundus biomicroscopy and spectral domain optical
coherence tomography (SD-OCT) (Spectralis; Heidelberg
Engineering, Heidelberg, Germany) of the macula.
IOL centration was evaluated after pupil dilation with
Tropicamide 0.5% and Phenylephrine Hydrochloride 10%
using a method described elsewhere [11]. Our 6.0 mm
optic diameter IOL was defined as decentered when its
optic edge was visible through 5.0 mm diameter pupil as a
result of tilt or subluxation greater than 1.0 mm.
The CDVA results were converted from Snellen to
logMAR notation for statistical analysis. The paired t –
test was used to compare between the preoperative and
the postoperative results of the spherical equivalent
(SEQ), refractive astigmatism, CDVA and IOP, and a
P value less than 0.05 was considered significant.
Results
Twelve patients, (five men and seven women) were in-
cluded in the cross-sectional study with mean age of
67 years (range, 50 to 85 years) and mean follow-up
period of 25 months (range, 12 to 37 months).
Ocular comorbidity included three patients with
regressed diabetic macular edema (DME) and regressedproliferative diabetic retinopathy (PDR) preoperatively
treated with focal laser and scatter laser, respectively;
one of them had optic atrophy as well.
The mean axial length was 23.27 ± 0.87 mm (22.15 to
24.70 mm), the mean keratometry (K) reading was 44.6 ±
1.8 Diopter (D) (42.35 to 49.02D) and the mean power of
the implanted IOL was 21.3D (15.5 to 26.0D).
Preoperatively, mean CDVA was 20/138 [0.84 ± 0.60 Log-
MAR; Counting Finger (CF) to 20/33] improving to 20/30
(0.18 ± 0.13 LogMAR; 20/40 to 20/20) at last examination
(p = 0.004), as all the patients gained better CDVA. Five pa-
tients out of twelve had final CDVA lower than 20/30: two
patients had regressed DME and regressed PDR, one of
whom had optic atrophy as well; the third had thick epiret-
inal membrane (ERM), vitreo-macular traction (VMT) syn-
drome and CME; the forth had stromal corneal opacity;
the fifth had posterior capsule opacity, awaiting posterior
capsulotomy.
Preoperative refraction was recorded in 10 of the 12
patients included in this study; 2 patients had brunes-
cent cataract and preoperative CDVA of CF interfering
with accurate refraction measurements.
The Mean preoperative spherical equivalent was −0.2 ±
2.5D (−4.0D to +5.4D) changing to −1.9 ± 0.9 (−4.0D to
−0.6D) at last examination (p = 0.12). The mean preopera-
tive refractive astigmatism magnitude was 1.0 ± 0.6D (0.3D
to 2.3D) reaching 1.1 ± 1.0D (0.0D to 3.0D) at last examin-
ation (p = 0.88).
One patient with brunescent cataract and preoperative
CDVA of CF, precluding preoperative subjective astig-
matism magnitude measurement, had a SEQ of −4.0D
and refractive astigmatism of 3D at last follow-up. Two
patients with preoperative corneal cylinder of 2.3D and
1.9D had a refractive astigmatism magnitude of 2.5D
and 1.75D, respectively, at last follow-up.
The remaining patients had postoperative SEQ and re-
fractive cylinder magnitude lower than 2.4D and 1.25D,
respectively, at last follow-up.
Mean preoperative IOP was 14.7 ± 3.2 mmHg (range,
11 to 23 mmHg) without medications reaching 15.9 ±
3.3 mmHg (range, 10 to 21 mmHg) at last follow up
(p = 0.21). During the postoperative follow-up period one pa-
tient developed glaucoma in both the study and the contra-
lateral eyes requiring two medications for IOP control.
None of the patients had symptoms of IOL edge glare
or TVO.
On slit lamp examination there were no cells, flare,
hemorrhage or vitreous incarceration in the anterior
chamber. In addition there were no pigment depositions
on the cornea or the IOL and the IOLs were well cen-
tered in all patients (Figures 2 and 3). Gonioscopy re-
vealed open angles with similar trabecular meshwork
pigmentation in each study eye compared to the contra-
lateral eye.
Figure 3 Anterior segment OCT images of a single-piece-acrylic
intraocular lens implanted in the ciliary sulcus. Horizontal (A) and
vertical (B) anterior segment OCT (Visante™OCT, Carl Zeiss Meditec, Inc.,
CA, USA), images of the right eye with sulcus-fixated single-piece-
acrylic intraocular lens (IOL), 6 months after phacoemulsification
complicated with large posterior capsule tear and vitreous loss. The
similar distance between the anterior edge of the IOL and the posterior
iris, indicates that there is no optic tilt.
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Clinical retinal examinations and SD-OCT revealed flat
maculas without hydration or cysts, except for one patient
who had thick ERM, VMT and CME. Accordingly, the
mean postoperative central foveal thickness measured by
SD-OCT was 280 ± 33 μm (range, 193 to 310 μm).
Discussion
Our results show that sulcus fixation of a SPA-IOL, de-
signed for both intracapsular and sulcus implantation,
may be safe and efficient as it resulted in significant im-
provement of the mean postoperative CDVA compared
to the preoperative records (20/30 versus 20/138; p =
0.004) without the associated complications reported
with sulcus fixation of other SPA-IOLs designed exclu-
sively for implantation in the capsular bag.
Pseudophakic PDS is the most common problem
within this group of complications. It is characterized by
increased pigmentation on the anterior surface of the
IOL, the corneal endothelial surface and the trabecular
meshwork and assumed to result from contact between
the PCIOL and the posterior iris leading to chafing of
the posterior iris pigment. Therefore it has been mostly
reported with sulcus fixated PCIOLs positioned in closeproximity to the posterior iris than with PCIOLs im-
planted in the capsular bag [12-15].
Moreover, sulcus placement of SPA-PCIOL designed
solely for capsular bag implantation may further increase
the risk of this complication [2-8]. It is thought that sev-
eral structural elements of these IOLs are responsible
for this finding [1,16]: 1. their haptics are thick and
bulky, allowing contact with the iris surface when placed
in the ciliary sulcus; 2. their shape is planar rather than
posteriorly angulated and, therefore, the optic does not
vault posteriorly from the iris; 3. their overall diameter
from haptic to haptic is shorter than the sulcus diameter,
enabling lateral decentration of the IOL with further
proximity to the posterior iris.
Unlike these IOLs, the SPA-PCIOL used in our study
was appropriate for ciliary sulcus implantation owing to
several features: 1.its haptics are thin (0.31 mm), minim-
izing the contact with the posterior iris surface; 2. its 5-
degree posterior haptics angulation moves the optic
away from the iris, thus reducing iris chafing by both
haptics and optics and providing sufficient posterior iris
clearance when placed in the ciliary sulcus; 3. its large
overall diameter of 13.0 mm may minimize the lens
movement [1], which can increase posterior iris chafing.
These unique features may explain the absence of PDS
in our patients. However, more data is required to con-
firm our observations.
Moreover, the pigment accumulating in the trabecular
meshwork may restrict aqueous outflow leading to sec-
ondary pigment dispersion glaucoma (PDG) [2,6,7]. Uy
and Chan [6] reported PDG in 3 of their patients (15%)
after SPA-PCIOL implantation in the ciliary sulcus. As
opposed, only one of our patients developed open angle
glaucoma postoperatively in both the study and the
contralateral eyes, without the typical PDG signs of pig-
ment scatter in the anterior chamber. The difference be-
tween our study and the other reports may be explained
by the unique characters of the SPA-PCIOL used in this
study, minimizing iris chafing, pigment liberation and
the consequent PDG.
Furthermore, PCIOL positioned in the sulcus in close
contact with the iris or the ciliary body may erode the uveal
vasculature causing vitreous hemorrhage [3-5] or may
break the blood–aqueous barrier leading to the uveitis-
glaucoma-hyphema (UGH) syndrome [8]. This syndrome is
composed of a spectrum of disorders including pigment
dispersion with or without intraocular pressure increase,
intermittent hyphema with TVO, or uveitis with or without
cystoid macular edema. Unlike these reports, none of our
patients had postoperative intraocular hemorrhage, inflam-
matory reaction, or symptoms of TVO. This discrepancy
may be elucidated by the structure of our IOL decreasing
its contact with the iris, but larger case series are needed to
validate this assumption.
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tory reaction were supported by macular SD-OCT re-
vealing absence of CME in all of our patients except for
one who had severe vitreo-retinal pathology leading to
macular traction and CME. However, more studies using
SD-OCT are required to validate our findings.
Another demand for any sulcus implanted IOLs is to keep
its central and steady positioning as decentered IOL with its
optic edge visible within the pupillary space may result in
glare symptoms [16]. Moreover, decentration of sulcus fix-
ated IOL may accentuate iris scraping and breakdown of the
blood–aqueous barrier leading to pigment dispersion and
UGH [16] and may induce myopia and astigmatism [17].
Brazitikos et al. [11] reported decentration of 1.0 to
2.0 mm in 5 cases (17.9%) after 3-piece acrylic PCIOL posi-
tioned in the sulcus. Therefore, an overall diameter of
13.0 mm has been recommended for sulcus fixated IOLs to
prevent subluxation and unexpected lens movement, in
addition to optic diameter of 6.0 mm to avoid glare symp-
toms in case of mild postoperative decentration [1].
As opposed, biomicroscopic examination with dilated
pupils did not reveal IOL decentration greater than
1.0 mm in any of our patients, and none of them had
glare symptoms. These observations may be explained
by sufficient capsule structure keeping the PCIOL posi-
tioning in the ciliary sulcus (Figure 1), and by the large
diameter of the IOL used in this study [1].
However, one of our patients had significant postoper-
ative myopia and astigmatism that may result from IOL
decentration smaller than 1 mm, which could not have
been discovered by the clinical examination used in this
study. On the other hand, De Castro et al. showed that
Scheimpflug Tomography Imaging system (Galilei) may
be valuable for demonstrating IOL decentration much
smaller than 1 mm [18]. Therefore, future studies using
this imaging modality are warranted to reveal the exact
anatomic positioning of sulcus fixated IOL’s.
The SPA-IOL used in this study was designed for both
in-the-bag and sulcus implantation through 2.4 mm
wound. This finding may have significant consequences
since it enables sulcus fixation of the original IOL model
selected for intracapsular implantation through the exis-
ting wound instead of switching to another backup IOLs
demanding wound enlargement.
Conclusions
Sulcus implantation of PCIOL during phacoemulsifica-
tion surgery complicated with PCT may be considered if
adequate lens is available and sufficient capsular support
exists. Our intermediate term follow-up after sulcus fix-
ation of a SPA-IOL designed for both intracapular and
sulcus implantation revealed good final CDVA and low
level of complications, though more research to ascer-
tain our results is warranted.Additional files
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